Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Y Nguyen HealthCare ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 5.8% 5.8%   Bankruptcy risk   8.1% 6.2% 5.4% 5.8% 6.7% 9.1% 14.6% 14.4%   Credit score (0-100)   31 39 42 38 35 21 2 3   Credit rating   B BB BB BB BB B B B   Credit limit (kDKK)   -0.0 0.0 0.0 0.0 0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -3.4 489 271 153 251 276 0.0 0.0   EBITDA   -3.4 421 107 32.4 -102 -89.6 0.0 0.0   EBIT   -9.5 377 58.1 -18.0 -171 -158 0.0 0.0   Pre-tax profit (PTP)   -9.5 376.1 57.5 -25.9 -189.6 -172.1 0.0 0.0   Net earnings   -9.5 282.1 56.9 -18.5 -148.4 -172.1 0.0 0.0   Pre-tax profit without non-rec. items   -9.5 376 57.5 -25.9 -190 -172 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   111 172 153 193 124 55.8 0.0 0.0   Shareholders equity total   -9.5 273 330 311 163 -9.5 -49.5 -49.5   Interest-bearing liabilities   147 22.8 1.2 359 429 517 49.5 49.5   Balance sheet total (assets)   140 428 452 719 645 576 0.0 0.0   Net Debt   133 -218 -74.9 331 401 493 49.5 49.5     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -3.4 489 271 153 251 276 0.0 0.0   Gross profit growth   0.0% 0.0% -44.5% -43.5% 63.5% 9.9% -100.0% 0.0%   Employees   0 1 1 1 0 2 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% -100.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   140 428 452 719 645 576 0 0   Balance sheet change%   0.0% 205.6% 5.5% 59.2% -10.4% -10.7% -100.0% 0.0%   Added value   -3.4 421.0 106.6 32.4 -120.2 -89.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   105 16 -68 -11 -137 -137 -56 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 1.0 2.0 -1.0 -2.0 -3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   279.7% 77.0% 21.4% -11.7% -68.0% -57.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -6.3% 130.3% 14.0% -3.1% -24.0% -25.7% 0.0% 0.0%   ROI %   -6.5% 165.8% 19.2% -3.6% -26.0% -28.5% 0.0% 0.0%   ROE %   -6.8% 136.7% 18.9% -5.8% -62.7% -46.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -6.3% 63.7% 72.9% 43.2% 25.2% -1.6% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -3,913.3% -51.9% -70.3% 1,022.1% -392.0% -550.4% 0.0% 0.0%   Gearing %   -1,547.8% 8.4% 0.4% 115.5% 263.6% -5,446.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.4% 34.3% 4.4% 6.5% 3.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.2 1.8 1.0 0.2 0.2 0.2 0.0 0.0   Current Ratio   0.2 1.8 1.0 0.2 0.2 0.2 0.0 0.0   Cash and cash equivalent   14.1 241.1 76.1 27.7 28.2 23.8 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -120.5 112.7 -0.8 -319.4 -384.8 -474.7 -24.7 -24.7   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 421 107 32 0 -45 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 421 107 32 0 -45 0 0   EBIT / employee   0 377 58 -18 0 -79 0 0   Net earnings / employee   0 282 57 -18 0 -86 0 0